期刊文献+

核仁磷酸蛋白基因突变对K562白血病细胞分化的影响

Effect of Nucleophosmin(NPM1) Mutations on the Differentiation of K562 Leukemic Cells
原文传递
导出
摘要 核仁磷酸蛋白基因(nucleophosmin,NPM1)突变在急性髓系白血病的发生发展中发挥着重要作用,而与白血病分化阻滞的关系尚未完全阐明。为探讨NPM1基因突变对白血病细胞体外分化的影响,将携带NPM1 A型突变(NPM1-mA)的表达质粒载体pEGFPC1-NPM1-mA转染白血病K562细胞系,构建稳定表达NPM1-mA蛋白的细胞株(K562 mA),同时设立野生型NPM1转染组(K562 wt)、空载体转染组(K562 C1)和未处理组(K562)为对照。利用豆蔻酰佛波醇乙酯(PMA)诱导各组细胞分化,瑞氏–吉姆萨染色观察细胞分化的形态改变,计算诱导分化率;相差显微镜计数贴壁细胞数量;流式细胞术分析细胞表面分化抗原CD41的表达。结果显示,PMA作用72 h后,与对照组相比,K562 mA组细胞的诱导分化率及贴壁细胞数明显降低(P<0.05);同时,CD41的表达受到显著抑制(P<0.01)。提示NPM1基因突变能够阻滞白血病细胞系K562的体外分化。 Nucleophosmin(NPM1) mutations play important roles in the leukemogenesis,whereas the relationship between NPM1 mutations and the differentiation block of leukemic cells have not yet been elucidated.To explore the effect of NPM1 mutations on the in vitro differentiation of leukemic cells,the plasmid pEGFPC1-NPM1-mA carrying NPM1 mutation A(NPM1-mA) was transfected into K562 cells,and the leukemic cells with stably expressed NPM1-mA protein(K562 mA) were established.The K562 cells transfected with pEGFPC1-NPM1-wt(K562 wt),pEGFP-C1(K562 C1) and the untreated cells(K562) were used as control.After induction with phorbol-12-myristate-13-acetate(PMA),the morphological changes of cells were observed under light microscope following Wright-Giemsa staining and the differentiation rate was estimated.Adherent cells were examined by phase contrast light microscopy.The expressions of surface marker CD41 were analyzed by flow cytometry.Compared with the control groups,the differentiation rates and the percentage of adherent cells in K562 mA group decreased obviously after PMA treatment for 72 h(P0.05).Meanwhile,the expression of CD41 was inhibited significantly in K562 mA group(P0.01).Our data indicate that NPM1 mutations block differentiation of K562 leukemic cells in vitro.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2012年第9期872-879,共8页 Chinese Journal of Cell Biology
基金 重庆市科委自然科学基金计划(No.2010BB5363)资助项目~~
关键词 白血病 NPM1突变 细胞分化 K562细胞系 leukemia NPM1 mutations cell differentiation K562 cell line
  • 相关文献

参考文献16

  • 1Vassiliou GS, Cooper JL, Rad R, Li J, Rice S, Uren A, et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat Genet 2011; 43(5): 470-5.
  • 2Bonetti P, Davoli T, Sironi C, Amati B, Pelicci PG, Colombo E. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J Cell Bio12008; 182(1): 19-26.
  • 3Cheng K, Sportoletti P, Ito K, Clohessy JG, Teruya-Feldstein J, Kutok JL, et al. The cytoplasmic NPM mutant induces myelo- proliferation in a transgenie mouse model. Blood 2010; 115(16): 3341-5.
  • 4Cheng K, Grisendi S, Clohessy JG, Majid S, Bemardi R, Spor-toletti P, et al. The eukemia-associated cytoplasmic nucleophos- min mutant is an oncogene with paradoxical functions: Arf in- activation and induction of cellular senescence. Oncogene 2007; 26(53): 7391-400.
  • 5邵会媛,苗宗玉,覃凤娴,陈先春,谭诗,张慧娟,等.NPMl突变基因通过MMPs参与调控白血病细胞体外侵袭.中国细胞生物学学报.
  • 6Falini B, Bolli N, Liso A, Martelli MP, Mannucci R, Pileri S, et al. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPMI: Molecular basis and clinical implications. Leukemia 2009; 23(10): 1731-43.
  • 7Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Mi- nardi SP, et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem- cell maintenance. Blood 2005; 106(3): 899-902.
  • 8Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Shar- rock K, Luke T, et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 2010; 115(10): 1976-84.
  • 9Nomdedeu J, Bussaglia E, Villamor N, Martinez C, Esteve J, Tormo M, et aL Immunophenotype of acute myeloid leukemia with NPM mutations: Prognostic impact of the leukemic com- partment size. Leuk Res 2011; 35(2): 163-8.
  • 10Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352(3): 254-66.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部